← All 31 country schedulesCompare on the schedule matrix

National Immunization Schedule · 2026

Australia vaccine schedule 2026 for babies and children

Australia's routine childhood vaccine schedule for babies and children, per NIP / ATAGI: 11 vaccines with dose timing and age at first dose, compared side by side with the U.S. CDC schedule. Australia and the United States share 11 routine vaccines. The U.S. routinely gives Hepatitis A, COVID-19,...

Source: National Immunisation Program Schedule (Australian Government / ATAGI) · last verified 2024-06-01 · official source

Reviewed by Matthew Thomas J Halma, Founder, Open Source Medicine Foundation · Last reviewed 2026-10-08

Australia childhood vaccine schedule: 11 vaccines by age

For babies (first year): Hepatitis B, DTaP / Tdap, Polio (IPV), Hib, Pneumococcal (PCV), Rotavirus, MMR, Varicella (chickenpox), Meningococcal. Click a vaccine for its Australia-specific page and its schedule in every other country.

VaccineStatusDoses & recommended age
Hepatitis B · side effects & dataUniversalDose 1 — At birth (Monovalent then hexavalent)
Dose 2 — 2 months (Monovalent then hexavalent)
Dose 3 — 4 months (Monovalent then hexavalent)
Dose 4 — 6 months (Monovalent then hexavalent)
DTaP / Tdap · side effects & dataUniversalDose 1 — 2 months
Dose 2 — 4 months
Dose 3 — 6 months
Booster — 18 months
Booster — 4 years
Polio (IPV) · side effects & dataUniversalDose 1 — 2 months (IPV)
Dose 2 — 4 months (IPV)
Dose 3 — 6 months (IPV)
Booster — 4 years (IPV)
Hib · side effects & dataUniversalDose 1 — 2 months
Dose 2 — 4 months
Dose 3 — 6 months
Booster — 18 months
Pneumococcal (PCV) · side effects & dataUniversalDose 1 — 2 months
Dose 2 — 4 months
Dose 3 — 6 months
Booster — 12 months
Rotavirus · side effects & dataUniversalDose 1 — 2 months (Rotavirus (oral))
Dose 2 — 4 months (Rotavirus (oral))
Dose 3 — 6 months (Rotavirus (oral))
MMR · side effects & dataUniversalDose 1 — 12 months (MMR or MMRV)
Dose 2 — 18 months (MMR or MMRV)
Varicella (chickenpox) · side effects & dataUniversalDose 1 — 18 months (MMRV)
Meningococcal · side effects & dataSelective / risk-basedMenB dose 1 — 2 months (MenB then MenACWY)
MenB dose 2 — 4 months (MenB then MenACWY)
MenB booster — 12 months (MenB then MenACWY)
MenACWY — 12 months (MenB then MenACWY)
MenACWY — 14-16 years (MenB then MenACWY)
HPV · side effects & dataUniversalDose 1 — 12-13 years
Dose 2 — 6-12 months after dose 1
Influenza (flu) · side effects & dataUniversalAnnual — 6 months-5 years and risk groups, every season

Australia vaccine schedule vs. the United States

Australia and the United States share 11 routine vaccines. The U.S. routinely gives Hepatitis A, COVID-19, which Australia does not.

VaccineAustralia first doseU.S. first doseDoses
Hepatitis BAt birthBirth4 vs 3 doses
DTaP / Tdap2 months2 months5 vs 5 doses
Polio (IPV)2 months2 months4 vs 4 doses
Hib2 months2 months4 vs 4 doses
Pneumococcal (PCV)2 months2 months4 vs 4 doses
Rotavirus2 months2 months3 vs 3 doses
MMR12 months12-15 months2 vs 2 doses
Varicella (chickenpox)18 months12-15 months1 vs 2 doses
Meningococcal2 months11-12 years5 vs 2 doses
HPV12-13 years11-12 years2 vs 2 doses
Influenza (flu)6 months-5 years and risk groups, every season6 months and older, every season1 vs 1 doses

In the routine U.S. schedule but not Australia's: Hepatitis A, COVID-19.

Why Australia's schedule looks the way it does

Schedules differ mostly because disease burden and health-system conditions differ. WHO/UNICEF estimates of how many children actually receive each vaccine, and the diseases' reported incidence, explain most of the choices below.

Coverage: share of children who received each vaccine (WHO/UNICEF estimates)

VaccineAustraliaUnited States
BCG (TB)not reportednot reported
DTP dose 192% (2025)98% (2025)
DTP dose 392% (2025)94% (2025)
Measles dose 191% (2025)92% (2025)
Measles dose 291% (2025)95% (2025)
Polio (IPV series)93% (2025)93% (2025)
Hep B birth dose65% (2025)75% (2025)
Hep B dose 394% (2025)93% (2025)
Hib dose 392% (2025)92% (2025)
Pneumococcal (PCV)94% (2025)84% (2025)
Rotavirus (complete)68% (2025)77% (2025)
HPV dose 1, girls75% (2025)73% (2025)

Source: WHO/UNICEF Estimates of National Immunization Coverage (WUENIC) and WHO reported incidence, via the WHO Immunization Data portal; TB incidence from the WHO Global Health Observatory (indicator MDG_0000000020). Retrieved 2026-10-09. "Not reported" usually means the vaccine is not in the universal schedule. Polio is the completed inactivated-polio series (IPVC).

Other Asia-Pacific countries

Indonesia · Japan · Philippines · South Korea · Vietnam · all 31 countries